Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-JK-PSMA-7 vs 18F-Fluorocholine in Prostate Cancer Recurrence
NCT05622162Phase 3Active, not recruiting
- Sponsor
- ITEL Telecomunicazioni
- Start
- Dec 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 18F-JK-PSMA-07 in prostate cancer (PCa), sponsored by ITEL Telecomunicazioni. Started Dec 2022; status: active, not recruiting.
02
Drugs
18F-JK-PSMA-07
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05622162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05622162.